Allan Steven Jacobson Ptc Therapeutics, Inc. (PTCT) insider trading activity

PTCT Quotes by TradingView

Allan Steven Jacobson is of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 17,451 shares of PTCT, which is worth approximately $1.31 Million. The most recent transaction as insider was on Nov 25, 2025, when has been sold 14,199 shares (Common Stock) at a price of $84.0 per share, resulting in proceeds of $1,192,716. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.5K
0% 3M change
14.24% 12M change
Total Value Held $1.31 Million

Allan Steven Jacobson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 25 2025
SELL
Open market or private sale
$1,192,716 $84.0 p/Share
14,199 Reduced 44.86%
17,451 Common Stock
Nov 25 2025
BUY
Exercise of conversion of derivative security
$207,589 $14.62 p/Share
14,199 Added 35.9%
25,351 Common Stock
Nov 24 2025
SELL
Open market or private sale
$945,732 $80.14 p/Share
11,801 Reduced 40.34%
17,451 Common Stock
Nov 24 2025
BUY
Exercise of conversion of derivative security
$172,530 $14.62 p/Share
11,801 Added 33.38%
23,551 Common Stock
Oct 03 2025
SELL
Open market or private sale
$780,000 $65.0 p/Share
12,000 Reduced 40.75%
17,451 Common Stock
Oct 03 2025
BUY
Exercise of conversion of derivative security
$370,320 $30.86 p/Share
12,000 Added 28.95%
29,451 Common Stock
Aug 28 2025
SELL
Open market or private sale
$83,600 $50.15 p/Share
1,667 Reduced 8.72%
17,451 Common Stock
Mar 04 2025
SELL
Open market or private sale
$63,369 $51.52 p/Share
1,230 Reduced 6.04%
19,118 Common Stock
Jan 03 2025
BUY
Grant, award, or other acquisition
-
4,000 Added 16.43%
20,348 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
4,000 Added 19.66%
16,348 Common Stock
Jan 22 2024
SELL
Open market or private sale
$273,800 $27.38 p/Share
10,000 Reduced 44.75%
12,348 Common Stock
Jan 22 2024
BUY
Exercise of conversion of derivative security
$270,500 $27.05 p/Share
10,000 Added 30.91%
22,348 Common Stock
May 11 2023
SELL
Open market or private sale
$1,288,920 $56.04 p/Share
23,000 Reduced 65.07%
12,348 Common Stock
May 11 2023
BUY
Exercise of conversion of derivative security
$249,550 $10.85 p/Share
23,000 Added 39.42%
35,348 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
4,000 Added 24.47%
12,348 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
3,200 Added 27.71%
8,348 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
1,650 Added 24.27%
5,148 Common Stock
Nov 04 2020
SELL
Open market or private sale
$1,200,000 $60.0 p/Share
20,000 Reduced 85.11%
3,498 Common Stock
Nov 04 2020
BUY
Exercise of conversion of derivative security
$217,000 $10.85 p/Share
20,000 Added 45.98%
23,498 Common Stock
Oct 16 2020
SELL
Open market or private sale
$256,450 $51.29 p/Share
5,000 Reduced 58.84%
3,498 Common Stock
ASJ

Allan Steven Jacobson

South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTCT